{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:11:01Z","timestamp":1790392261227,"version":"4.1.0"},"reference-count":294,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011856","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Glucocorticoid (GC) hormones are secreted in a circadian and ultradian rhythm and play a critical role in maintaining physiological homeostasis, with both excess and insufficient GC associated with adverse effects on health. Current assessment of GC status is primarily clinical, often in conjunction with serum cortisol values, which may be stimulated or suppressed depending on the GC disturbance being assessed. In the setting of extreme perturbations in cortisol levels ie, markedly low or high levels, symptoms and signs of GC dysfunction may be overt. However, when disturbances in cortisol GC status values are less extreme, such as when assessing optimization of a GC replacement regimen, signs and symptoms can be more subtle or nonspecific. Current tools for assessing GC status are best suited to identifying profound disturbances but may lack sensitivity for confirming optimal GC status. Moreover, single cortisol values do not necessarily reflect an individual's GC status, as they are subject to inter- and intraindividual variation and do not take into account the pulsatile nature of cortisol secretion, variation in binding proteins, or local tissue concentrations as dictated by 11beta-hydroxysteroid dehydrogenase activity, as well as GC receptor sensitivity. In the present review, we evaluate possible alternative methods for the assessment of GC status that do not solely rely on the measurement of circulating cortisol levels. We discuss the potential of changes in metabolomic profiles, micro RNA, gene expression, and epigenetic and other novel biomarkers such as growth differentiating factor 15 and osteocalcin, which could in the future aid in the objective classification of GC status.<\/jats:p>","DOI":"10.1210\/endrev\/bnae016","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:51:54Z","timestamp":1716659514000},"page":"795-817","source":"Crossref","is-referenced-by-count":32,"title":["Current Challenges and Future Directions in the Assessment of Glucocorticoid Status"],"prefix":"10.1210","volume":"45","author":[{"given":"Sophie A","family":"Clarke","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4172-1344","authenticated-orcid":false,"given":"Pei Chia","family":"Eng","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]},{"name":"Department of Endocrinology , National University of Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-2297","authenticated-orcid":false,"given":"Alexander N","family":"Comninos","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0758-7839","authenticated-orcid":false,"given":"Katharine","family":"Lazarus","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-005X","authenticated-orcid":false,"given":"Sirazum","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Tsang","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7112-2756","authenticated-orcid":false,"given":"Karim","family":"Meeran","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-3432","authenticated-orcid":false,"given":"Tricia M","family":"Tan","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-4316","authenticated-orcid":false,"given":"Waljit S","family":"Dhillo","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-5256","authenticated-orcid":false,"given":"Ali","family":"Abbara","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine, Imperial College London , London W12 ONN ,","place":["UK"]},{"name":"Department of Endocrinology, Imperial College Healthcare NHS Trust , London W6 8RF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"1","key":"2024112123520564400_bnae016-B1","doi-asserted-by":"crossref","first-page":"e15766","DOI":"10.1371\/journal.pone.0015766","article-title":"Ultradian cortisol pulsatility encodes a distinct, biologically important signal","volume":"6","author":"McMaster","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"2024112123520564400_bnae016-B2","doi-asserted-by":"crossref","first-page":"bnaa002","DOI":"10.1210\/endrev\/bnaa002","article-title":"Dynamics of ACTH and cortisol secretion and implications for disease","volume":"41","author":"Lightman","year":"2020","journal-title":"Endocr Rev"},{"issue":"7","key":"2024112123520564400_bnae016-B3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2024112123520564400_bnae016-B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-021-00252-7","article-title":"Adrenal insufficiency","volume":"7","author":"Hahner","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2024112123520564400_bnae016-B5","doi-asserted-by":"crossref","first-page":"e85204","DOI":"10.1371\/journal.pone.0085204","article-title":"Deconvolution of serum cortisol levels by using compressed sensing","volume":"9","author":"Faghih","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"2024112123520564400_bnae016-B6","doi-asserted-by":"crossref","first-page":"e13401","DOI":"10.1111\/obr.13401","article-title":"Variation in glucocorticoid sensitivity and the relation with obesity","volume":"23","author":"Lengton","year":"2022","journal-title":"Obes Rev"},{"issue":"5","key":"2024112123520564400_bnae016-B7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.beem.2017.10.011","article-title":"Human studies on hypothalamo-pituitary-adrenal (HPA) axis","volume":"31","author":"Liyanarachchi","year":"2017","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"2024112123520564400_bnae016-B8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physiolgenomics.00001.2012","article-title":"Entrainment of peripheral clock genes by cortisol","volume":"44","author":"Mavroudis","year":"2012","journal-title":"Physiol Genomics"},{"issue":"9","key":"2024112123520564400_bnae016-B9","doi-asserted-by":"crossref","first-page":"e25612","DOI":"10.1371\/journal.pone.0025612","article-title":"Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man","volume":"6","author":"Charmandari","year":"2011","journal-title":"PLoS One"},{"key":"2024112123520564400_bnae016-B10","doi-asserted-by":"crossref","first-page":"759234","DOI":"10.1155\/2010\/759234","article-title":"Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity","volume":"2010","author":"Balbo","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"4 Pt 1","key":"2024112123520564400_bnae016-B11","first-page":"E608","article-title":"Internal dissociation of the circadian markers of the cortisol rhythm in night workers","volume":"270","author":"Weibel","year":"1996","journal-title":"Am J Physiol"},{"issue":"1 Pt 2","key":"2024112123520564400_bnae016-B12","first-page":"R261","article-title":"The circadian melatonin and cortisol secretion pattern in permanent night shift workers","volume":"265","author":"Roden","year":"1993","journal-title":"Am J Physiol"},{"issue":"6","key":"2024112123520564400_bnae016-B13","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid- induced metabolic changes: a novel mechanism in Cushing's syndrome","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"},{"issue":"5","key":"2024112123520564400_bnae016-B14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.beem.2015.09.001","article-title":"Corticosteroid-binding globulin: modulating mechanisms of bioavailability of cortisol and its clinical implications","volume":"29","author":"Bae","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2024112123520564400_bnae016-B15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0042-108071","article-title":"Corticosteroid-binding globulin: a review of basic and clinical advances","volume":"48","author":"Meyer","year":"2016","journal-title":"Horm Metab Res"},{"issue":"10","key":"2024112123520564400_bnae016-B16","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1210\/jc.2019-00022","article-title":"Plasma free cortisol in states of normal and altered binding globulins: implications for adrenal insufficiency diagnosis","volume":"104","author":"Dichtel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2006-925338","article-title":"Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin","volume":"38","author":"Lewis","year":"2006","journal-title":"Horm Metab Res"},{"issue":"2","key":"2024112123520564400_bnae016-B18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/jpem-2017-0270","article-title":"The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency","volume":"31","author":"Verbeeten","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"16","key":"2024112123520564400_bnae016-B19","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","article-title":"Measurements of serum free cortisol in critically ill patients","volume":"350","author":"Hamrahian","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2024112123520564400_bnae016-B20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1258\/acb.2009.009101","article-title":"The diagnosis and investigation of adrenal insufficiency in adults","volume":"46","author":"Wallace","year":"2009","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"2024112123520564400_bnae016-B21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1210\/jc.2006-1791","article-title":"Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents","volume":"92","author":"Klose","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2024112123520564400_bnae016-B22","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0024-3205(97)00926-0","article-title":"With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens","volume":"61","author":"Deuschle","year":"1997","journal-title":"Life Sci"},{"issue":"10","key":"2024112123520564400_bnae016-B23","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.psyneuen.2013.05.003","article-title":"A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults","volume":"38","author":"Dmitrieva","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"2024112123520564400_bnae016-B24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1530\/EC-17-0160","article-title":"Impact of age, sex and body mass index on cortisol secretion in 143 healthy adults","volume":"6","author":"Roelfsema","year":"2017","journal-title":"Endocr Connect"},{"issue":"7","key":"2024112123520564400_bnae016-B25","first-page":"2468","article-title":"Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol","volume":"81","author":"Van Cauter","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1037\/a0017910","article-title":"Interindividual differences and intraindividual variability in the cortisol awakening response: an examination of age and gender","volume":"24","author":"Almeida","year":"2009","journal-title":"Psychol Aging"},{"issue":"11","key":"2024112123520564400_bnae016-B27","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.psyneuen.2013.06.010","article-title":"Daytime trajectories of cortisol: demographic and socioeconomic differences\u2014findings from the National Study of Daily Experiences","volume":"38","author":"Karlamangla","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"2024112123520564400_bnae016-B28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.psychres.2011.09.009","article-title":"Biological sex and menstrual cycle phase modulation of cortisol levels and psychiatric symptoms in a non-clinical sample of young adults","volume":"197","author":"Walder","year":"2012","journal-title":"Psychiatry Res"},{"key":"2024112123520564400_bnae016-B29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpsycho.2018.03.021","article-title":"The relationship between the menstrual cycle and cortisol secretion: daily and stress-invoked cortisol patterns","volume":"131","author":"Montero-L\u00f3pez","year":"2018","journal-title":"Int J Psychophysiol"},{"key":"2024112123520564400_bnae016-B30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fendo.2020.00311","article-title":"Higher circulating cortisol in the follicular vs. luteal phase of the menstrual cycle: a meta-analysis","volume":"11","author":"Hamidovic","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024112123520564400_bnae016-B31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00006842-199903000-00006","article-title":"Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis","volume":"61","author":"Kirschbaum","year":"1999","journal-title":"Psychosom Med"},{"issue":"5","key":"2024112123520564400_bnae016-B32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/cen.12039","article-title":"Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays","volume":"78","author":"El-Farhan","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024112123520564400_bnae016-B33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563216687335","article-title":"Measuring cortisol in serum, urine and saliva\u2014are our assays good enough?","volume":"54","author":"El-Farhan","year":"2017","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"2024112123520564400_bnae016-B34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/jcp.15.4.374","article-title":"A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma","volume":"15","author":"Mattingly","year":"1962","journal-title":"J Clin Pathol"},{"issue":"3","key":"2024112123520564400_bnae016-B35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-2944(73)90056-2","article-title":"A radioimmunoassay for cortisol in human plasma","volume":"7","author":"Campuzano","year":"1973","journal-title":"Biochem Med"},{"issue":"9","key":"2024112123520564400_bnae016-B36","first-page":"531","article-title":"A fully automated enzyme immunoassay for the measurement of cortisol in biological fluids","volume":"30","author":"Bacarese-Hamilton","year":"1992","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"12","key":"2024112123520564400_bnae016-B37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinbiochem.2009.04.011","article-title":"Cortisol assays and diagnostic laboratory procedures in human biological fluids","volume":"42","author":"Gatti","year":"2009","journal-title":"Clin Biochem"},{"issue":"5","key":"2024112123520564400_bnae016-B38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11102-016-0730-5","article-title":"Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing's syndrome","volume":"19","author":"Aranda","year":"2016","journal-title":"Pituitary"},{"key":"2024112123520564400_bnae016-B39"},{"issue":"5","key":"2024112123520564400_bnae016-B40","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1210\/jc.2012-3576","article-title":"Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH1\u201324 stimulation in the assessment of pituitary patients","volume":"98","author":"Burt","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B41","doi-asserted-by":"crossref","first-page":"234808","DOI":"10.1155\/2010\/234808","article-title":"Agreement of immunoassay and tandem mass spectrometry in the analysis of cortisol and free T4: interpretation and implications for clinicians","volume":"2010","author":"Tractenberg","year":"2010","journal-title":"Int J Anal Chem"},{"issue":"4","key":"2024112123520564400_bnae016-B42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3803\/EnM.2022.1549","article-title":"Clinical and technical aspects in free cortisol measurement","volume":"37","author":"Choi","year":"2022","journal-title":"Endocrinol Metab"},{"issue":"5","key":"2024112123520564400_bnae016-B43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/acb.2011.011014","article-title":"Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11 \u03b2 -hydroxylase inhibitor metyrapone","volume":"48","author":"Monaghan","year":"2011","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"2024112123520564400_bnae016-B44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1258\/acb.2011.010250","article-title":"Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing's syndrome","volume":"48","author":"Djedovic","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"2024112123520564400_bnae016-B45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.aca.2013.12.030","article-title":"Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry","volume":"812","author":"Marcos","year":"2014","journal-title":"Anal Chim Acta"},{"issue":"1","key":"2024112123520564400_bnae016-B46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/00045632211040059","article-title":"LC-MS\/MS the first 20 years: a personal view","volume":"59","author":"Keevil","year":"2022","journal-title":"Ann Clin Biochem"},{"key":"2024112123520564400_bnae016-B47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2016.05.014","article-title":"Endogenous glucocorticoid analysis by liquid chromatography\u2013tandem mass spectrometry in routine clinical laboratories","volume":"162","author":"Hawley","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"2024112123520564400_bnae016-B48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrendo.2012.134","article-title":"Regulation of cortisol bioavailability\u2013effects on hormone measurement and action","volume":"8","author":"Perogamvros","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"11-12","key":"2024112123520564400_bnae016-B49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cca.2011.02.019","article-title":"Free cortisol method comparison: ultrafiltation, equilibrium dialysis, tracer dilution, tandem mass spectrometry and calculated free cortisol","volume":"412","author":"Pretorius","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2024112123520564400_bnae016-B50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jc.2005-0265","article-title":"Septic shock and sepsis: a comparison of total and free plasma cortisol levels","volume":"91","author":"Ho","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024112123520564400_bnae016-B51","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2013.08.028","article-title":"Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosis","volume":"12","author":"Fede","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2024112123520564400_bnae016-B52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2010.05.020","article-title":"Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease","volume":"53","author":"Tan","year":"2010","journal-title":"J Hepatol"},{"issue":"5","key":"2024112123520564400_bnae016-B53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1365-2265.2000.00984.x","article-title":"Low-dose (1 \u03bcg) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 \u03bcg) test: the low dose ACTH test for HPA assessment","volume":"52","author":"Tordjman","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024112123520564400_bnae016-B54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2265.2005.02421.x","article-title":"Assessing the HPA axis in patients with pituitary disease: a UK survey","volume":"64","author":"Reynolds","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2024112123520564400_bnae016-B55","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/cen.14071","article-title":"Validated criteria for the interpretation of a single measurement of serum cortisol in the investigation of suspected adrenal insufficiency","volume":"91","author":"Mackenzie","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2024112123520564400_bnae016-B56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmed.2019-0324","article-title":"Guidance for the prevention and emergency management of adult patients with adrenal insufficiency","volume":"20","author":"Simpson","year":"2020","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"2024112123520564400_bnae016-B57","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1530\/EJE-20-0894","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: residual adrenal function in Addison's disease","volume":"184","author":"Pearce","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024112123520564400_bnae016-B58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/cen.12117","article-title":"What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?","volume":"78","author":"Debono","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2024112123520564400_bnae016-B59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Esposito","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024112123520564400_bnae016-B60","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024112123520564400_bnae016-B61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7861\/clinmedicine.17-3-258","article-title":"Adrenal insufficiency\u2014recognition and management","volume":"17","author":"Pazderska","year":"2017","journal-title":"Clin Med"},{"key":"2024112123520564400_bnae016-B62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2020.01.029","article-title":"Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges","volume":"505","author":"Martin-Grace","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2024112123520564400_bnae016-B63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5362","key":"2024112123520564400_bnae016-B64","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/bmj.2.5362.887","article-title":"Eighty-six cases of Addison's disease","volume":"2","author":"Dunlop","year":"1963","journal-title":"Br Med J"},{"issue":"12","key":"2024112123520564400_bnae016-B65","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024112123520564400_bnae016-B66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1515\/jpem-2019-0030","article-title":"The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience","volume":"32","author":"Ventura","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10274","key":"2024112123520564400_bnae016-B67","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"key":"2024112123520564400_bnae016-B68","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fendo.2019.00766","article-title":"Toward a diagnostic score in Cushing's syndrome","volume":"10","author":"Braun","year":"2019","journal-title":"Front Endocrinol"},{"issue":"8","key":"2024112123520564400_bnae016-B69","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024112123520564400_bnae016-B70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024112123520564400_bnae016-B71","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing's disease","volume":"90","author":"van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/CLEP.S44336","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Feelders","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"9996","key":"2024112123520564400_bnae016-B73","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"2024112123520564400_bnae016-B74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing's syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"J Physiol"},{"issue":"3","key":"2024112123520564400_bnae016-B75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: the burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024112123520564400_bnae016-B76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2024112123520564400_bnae016-B77","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2008-0710","article-title":"Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis","volume":"93","author":"Kazlauskaite","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024112123520564400_bnae016-B78","first-page":"435","article-title":"Establishment of reference values for endocrine tests. Part IV: adrenal insufficiency","volume":"63","author":"Endert","year":"2005","journal-title":"Neth J Med"},{"issue":"11","key":"2024112123520564400_bnae016-B79","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B80","doi-asserted-by":"crossref","first-page":"bvab022","DOI":"10.1210\/jendso\/bvab022","article-title":"New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays","volume":"5","author":"Javorsky","year":"2021","journal-title":"J Endocr Soc"},{"issue":"1","key":"2024112123520564400_bnae016-B81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2012.04478.x","article-title":"Determining the utility of the 60\u2005minutes cortisol measurement in the short synacthen test","volume":"79","author":"Chitale","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024112123520564400_bnae016-B82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/cen.12397","article-title":"Different cut-off values of the insulin tolerance test, the high-dose short synacthen test (250 \u03bcg) and the low-dose short synacthen test (1 \u03bcg) in assessing central adrenal insufficiency","volume":"81","author":"Cho","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2024112123520564400_bnae016-B83","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/cen.12043","article-title":"Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism","volume":"78","author":"Cegla","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2024112123520564400_bnae016-B84","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1210\/jc.2001-011959","article-title":"Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function","volume":"87","author":"Berneis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024112123520564400_bnae016-B85","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1210\/jc.2003-030510","article-title":"Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome","volume":"88","author":"Isidori","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024112123520564400_bnae016-B86","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/jc.2003-030207","article-title":"The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome","volume":"89","author":"Findling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024112123520564400_bnae016-B87","first-page":"315","article-title":"Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy","volume":"75","author":"Kyriazopoulou","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024112123520564400_bnae016-B88","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1210\/jc.2015-2507","article-title":"Screening tests for Cushing's syndrome: urinary free cortisol role measured by LC-MS\/MS","volume":"100","author":"Ceccato","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024112123520564400_bnae016-B89","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024112123520564400_bnae016-B90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing's disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024112123520564400_bnae016-B91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/clinchem\/48.1.207","article-title":"Comparison of two methods for measuring salivary cortisol","volume":"48","author":"Raff","year":"2002","journal-title":"Clin Chem"},{"issue":"2","key":"2024112123520564400_bnae016-B92","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem.83.2.4555","article-title":"High fluid intake increases urine free cortisol excretion in normal subjects","volume":"83","author":"Mericq","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B93","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2003.029934","article-title":"Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"issue":"5","key":"2024112123520564400_bnae016-B94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1995.tb02918.x","article-title":"A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome","volume":"43","author":"Newell-Price","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024112123520564400_bnae016-B95","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/eje.1.02042","article-title":"Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome","volume":"153","author":"Reimondo","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2024112123520564400_bnae016-B96","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024112123520564400_bnae016-B97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2018.5","article-title":"Imitating the cortisol profile improves the immune system","volume":"14","author":"M\u00fcller","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2024112123520564400_bnae016-B98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2024112123520564400_bnae016-B99","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1530\/EC-20-0473","article-title":"The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism","volume":"10","author":"Choudhury","year":"2021","journal-title":"Endocr Connect"},{"issue":"2","key":"2024112123520564400_bnae016-B100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/jalm.2016.020206","article-title":"Prednisolone replacement therapy mimics the circadian rhythm more closely than other glucocorticoids","volume":"1","author":"Williams","year":"2016","journal-title":"J Appl Lab Med"},{"issue":"3","key":"2024112123520564400_bnae016-B101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2024112123520564400_bnae016-B102","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/cen.13999","article-title":"Improving glucocorticoid replacement profiles in adrenal insufficiency","volume":"91","author":"Choudhury","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024112123520564400_bnae016-B103","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2213-8587(20)30149-2","article-title":"Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection","volume":"8","author":"Isidori","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2024112123520564400_bnae016-B104","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1210\/jc.2014-2433","article-title":"Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B105","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2002-021518","article-title":"Gender-related differences in the presentation and course of Cushing's disease","volume":"88","author":"Giraldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9522","key":"2024112123520564400_bnae016-B106","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"2024112123520564400_bnae016-B107","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1172\/JCI106042","article-title":"Parotid fluid cortisol and cortisone","volume":"48","author":"Katz","year":"1969","journal-title":"J Clin Invest"},{"issue":"29","key":"2024112123520564400_bnae016-B108","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1016\/j.jchromb.2009.09.014","article-title":"Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography\u2013tandem mass spectrometry: application in basal and stimulated conditions","volume":"877","author":"Perogamvros","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"11","key":"2024112123520564400_bnae016-B109","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/jc.2010-1215","article-title":"Salivary cortisone is a potential biomarker for serum free cortisol","volume":"95","author":"Perogamvros","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B110","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1210\/jc.2015-3694","article-title":"Salivary cortisone reflects cortisol exposure under physiological conditions and after hydrocortisone","volume":"101","author":"Debono","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024112123520564400_bnae016-B111","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200182","article-title":"Home waking salivary cortisone to screen for adrenal insufficiency","volume":"2","author":"Debono","year":"2023","journal-title":"NEJM Evid"},{"issue":"7","key":"2024112123520564400_bnae016-B112","doi-asserted-by":"crossref","first-page":"e220050","DOI":"10.1530\/EC-22-0050","article-title":"Late-night salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome","volume":"11","author":"Mohamed","year":"2022","journal-title":"Endocr Connect"},{"issue":"3","key":"2024112123520564400_bnae016-B113","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MED.0000000000000328","article-title":"Salivary cortisol and cortisone in the clinical setting","volume":"24","author":"Blair","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"2024112123520564400_bnae016-B114","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1210\/jc.2016-1228","article-title":"Measurement of salivary cortisone to assess the adequacy of hydrocortisone replacement","volume":"101","author":"Raff","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024112123520564400_bnae016-B115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jc.2018-01172","article-title":"Salivary cortisone to estimate cortisol exposure and sampling frequency required based on Serum cortisol measurements","volume":"104","author":"Harrison","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024112123520564400_bnae016-B116","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2265.2012.04508.x","article-title":"Measurement of salivary cortisol in 2012\u2014laboratory techniques and clinical indications","volume":"77","author":"Inder","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024112123520564400_bnae016-B117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.psyneuen.2012.04.019","article-title":"Comparison of salivary cortisol as measured by different immunoassays and tandem mass spectrometry","volume":"38","author":"Miller","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"2024112123520564400_bnae016-B118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10552-017-0989-5","article-title":"Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors","volume":"29","author":"Frug\u00e9","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"Suppl 1","key":"2024112123520564400_bnae016-B119","doi-asserted-by":"crossref","first-page":"A30","DOI":"10.1210\/jendso\/bvab048.057","article-title":"The relation between cortisol and anthropometric measurements throughout lifespan: a systematic review and meta-analysis","volume":"5","author":"van der Valk","year":"2021","journal-title":"J Endocr Soc"},{"issue":"2","key":"2024112123520564400_bnae016-B120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0029-1220771","article-title":"Hair analysis provides a historical record of cortisol levels in Cushing's syndrome","volume":"118","author":"Thomson","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2024112123520564400_bnae016-B121","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/cen.12551","article-title":"Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy","volume":"81","author":"Noppe","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024112123520564400_bnae016-B122","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2014-4328","article-title":"Increased hair cortisol concentrations and BMI in patients with pituitary-adrenal disease on hydrocortisone replacement","volume":"100","author":"Staufenbiel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024112123520564400_bnae016-B123","doi-asserted-by":"crossref","first-page":"E1836","DOI":"10.1210\/jc.2012-1852","article-title":"A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair","volume":"97","author":"Manenschijn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024112123520564400_bnae016-B124","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.2011.04001.x","article-title":"Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy","volume":"74","author":"Gow","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024112123520564400_bnae016-B125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/dev.21830","article-title":"Innovations in biological assessments of chronic stress through hair and nail cortisol: conceptual, developmental, and methodological issues","volume":"61","author":"Liu","year":"2019","journal-title":"Dev Psychobiol"},{"issue":"3","key":"2024112123520564400_bnae016-B126","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"issue":"1","key":"2024112123520564400_bnae016-B127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2337\/db08-0969","article-title":"Cortisol release from adipose tissue by 11\u03b2-hydroxysteroid dehydrogenase type 1 in humans","volume":"58","author":"Stimson","year":"2009","journal-title":"Diabetes"},{"issue":"8","key":"2024112123520564400_bnae016-B128","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2337\/diabetes.53.8.2051","article-title":"Splanchnic cortisol production occurs in HumansEvidence for conversion of cortisone to cortisol via the 11-\u03b2 hydroxysteroid dehydrogenase (11\u03b2-HSD) type 1 pathway","volume":"53","author":"Basu","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"2024112123520564400_bnae016-B129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/endo.142.1.7887","article-title":"Intracellular regeneration of glucocorticoids by 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11\u03b2-HSD-1-deficient mice*the wellcome trust supported this work through a program grant (to J.J.M. and J.R.S.) and a career development fellowship (to M.C.H.)","volume":"142","author":"Harris","year":"2001","journal-title":"Endocrinology"},{"issue":"5549","key":"2024112123520564400_bnae016-B130","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"issue":"26","key":"2024112123520564400_bnae016-B131","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2024112123520564400_bnae016-B132","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2002-030017","article-title":"Subcutaneous adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians","volume":"88","author":"Lindsay","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024112123520564400_bnae016-B133","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2003-030286","article-title":"Local and systemic impact of transcriptional up-regulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity","volume":"88","author":"Wake","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024112123520564400_bnae016-B134","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1210\/jc.2002-020687","article-title":"Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity","volume":"87","author":"Tomlinson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024112123520564400_bnae016-B135","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00125-004-1407-6","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle","volume":"47","author":"Nair","year":"2004","journal-title":"Diabetologia"},{"issue":"11","key":"2024112123520564400_bnae016-B136","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1210\/jc.2001-011375","article-title":"Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism","volume":"87","author":"Draper","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024112123520564400_bnae016-B137","first-page":"57","article-title":"Absence of cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion","volume":"87","author":"Tomlinson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024112123520564400_bnae016-B138","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2002-021194","article-title":"Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes","volume":"88","author":"Andrews","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024112123520564400_bnae016-B139","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"2024112123520564400_bnae016-B140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41467-023-36541-w","article-title":"11\u03b2-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial","volume":"14","author":"Othonos","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"2024112123520564400_bnae016-B141","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/13543784.17.4.481","article-title":"11-Beta-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) inhibitors in type 2 diabetes mellitus and obesity","volume":"17","author":"Hughes","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"2024112123520564400_bnae016-B142","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0960-0760(02)00062-6","article-title":"Glucocorticoid receptor variants: clinical implications","volume":"81","author":"DeRijk","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024112123520564400_bnae016-B143","author":"Nicolaides"},{"issue":"1","key":"2024112123520564400_bnae016-B144","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids-mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"2024112123520564400_bnae016-B145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-physiol-021115-105323","article-title":"Glucocorticoid signaling: an update from a genomic perspective","volume":"78","author":"Sacta","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"2024112123520564400_bnae016-B146","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2024112123520564400_bnae016-B147","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/ijms20010079","article-title":"Hsp90 heterocomplexes regulate steroid hormone receptors: from stress response to psychiatric disease","volume":"20","author":"Baker","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2024112123520564400_bnae016-B148","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2018.03.001","article-title":"Pathophysiology of glucocorticoid signaling","volume":"79","author":"Vitellius","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"2024112123520564400_bnae016-B149","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13679-018-0306-y","article-title":"Stress and obesity: are there more susceptible individuals?","volume":"7","author":"van der Valk","year":"2018","journal-title":"Curr Obes Rep"},{"issue":"6","key":"2024112123520564400_bnae016-B150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-2600(18)30058-4","article-title":"Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study","volume":"6","author":"Hawcutt","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"9","key":"2024112123520564400_bnae016-B151","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1007\/s12035-016-0251-2","article-title":"Dexamethasone alters the appetite regulation via induction of hypothalamic insulin resistance in rat brain","volume":"54","author":"Chruvattil","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"9","key":"2024112123520564400_bnae016-B152","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/jne.12157","article-title":"Novel aspects of glucocorticoid actions","volume":"26","author":"Uchoa","year":"2014","journal-title":"J Neuroendocrinol"},{"issue":"10","key":"2024112123520564400_bnae016-B153","first-page":"1066","article-title":"Reversibility of gastric dysmotility in cortisol deficiency","volume":"82","author":"Valenzuela","year":"1987","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2024112123520564400_bnae016-B154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nutres.2013.12.006","article-title":"A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans","volume":"34","author":"Berthon","year":"2014","journal-title":"Nutr Res"},{"issue":"12","key":"2024112123520564400_bnae016-B155","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"Di","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"2024112123520564400_bnae016-B156","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1474-4422(10)70021-1","article-title":"Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial","volume":"9","author":"van Schaik","year":"2010","journal-title":"Lancet Neurol"},{"issue":"2 Pt 1","key":"2024112123520564400_bnae016-B157","first-page":"E317","article-title":"Effects of glucocorticoids on energy metabolism and food intake in humans","volume":"271","author":"Tataranni","year":"1996","journal-title":"Am J Physiol"},{"issue":"7","key":"2024112123520564400_bnae016-B158","doi-asserted-by":"crossref","first-page":"e1004474","DOI":"10.1371\/journal.pgen.1004474","article-title":"Genome wide association identifies common variants at the SERPINA6\/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin","volume":"10","author":"Bolton","year":"2014","journal-title":"PLoS Genet"},{"issue":"5","key":"2024112123520564400_bnae016-B159","doi-asserted-by":"crossref","first-page":"e1954","DOI":"10.1210\/clinem\/dgac008","article-title":"The role of morning plasma cortisol in obesity: a bidirectional Mendelian randomization study","volume":"107","author":"Qi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/oby.21790","article-title":"Stress, cortisol, and other appetite-related hormones: prospective prediction of 6-month changes in food cravings and weight","volume":"25","author":"Chao","year":"2017","journal-title":"Obesity"},{"issue":"3","key":"2024112123520564400_bnae016-B161","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-09-0884","article-title":"Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies","volume":"162","author":"Hahner","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024112123520564400_bnae016-B162","first-page":"142","article-title":"Addison's disease\u2014serological studies","volume":"76","author":"Nerup","year":"1974","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2024112123520564400_bnae016-B163","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0893-133X(95)00066-M","article-title":"Hormonal control of rat adrenal phenylethanolamine N-methyltransferase enzyme activity, the final critical pathway","volume":"13","author":"Wong","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2024112123520564400_bnae016-B164","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1152\/ajplegacy.1951.165.2.456","article-title":"Action of adrenal cortical steroids and nor-epinephrine on vascular responses of stress in adrenalectomized rats","volume":"165","author":"Fritz","year":"1951","journal-title":"Am J Physiol"},{"issue":"12","key":"2024112123520564400_bnae016-B165","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jcem.86.12.8106","article-title":"The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency","volume":"86","author":"Zuckerman-Levin","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B166","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fendo.2019.00321","article-title":"The pathophysiology and treatment of hypertension in patients with Cushing's syndrome","volume":"10","author":"Barbot","year":"2019","journal-title":"Front Endocrinol"},{"issue":"3","key":"2024112123520564400_bnae016-B167","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.13059","article-title":"Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison's disease","volume":"85","author":"van der Valk","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024112123520564400_bnae016-B168","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0733-8619(03)00053-7","article-title":"Neuromuscular manifestations of endocrine disorders","volume":"20","author":"Alshekhlee","year":"2002","journal-title":"Neurol Clin"},{"issue":"1","key":"2024112123520564400_bnae016-B169","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"5","key":"2024112123520564400_bnae016-B170","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/WNL.48.5.1234","article-title":"Steroid myopathy in cancer patients","volume":"48","author":"Batchelor","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"2024112123520564400_bnae016-B171","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bmt.1705435","article-title":"Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy","volume":"38","author":"Lee","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2024112123520564400_bnae016-B172","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"2024112123520564400_bnae016-B173","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12020-017-1472-5","article-title":"Diagnostic work-up in steroid myopathy","volume":"60","author":"Minetto","year":"2018","journal-title":"Endocrine"},{"issue":"5","key":"2024112123520564400_bnae016-B174","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"2024112123520564400_bnae016-B175","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jcsm.12315","article-title":"Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy","volume":"9","author":"Gueugneau","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6628","key":"2024112123520564400_bnae016-B176","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"issue":"5","key":"2024112123520564400_bnae016-B177","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.10-176917","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"FASEB J"},{"issue":"5","key":"2024112123520564400_bnae016-B178","doi-asserted-by":"crossref","first-page":"e0156225","DOI":"10.1371\/journal.pone.0156225","article-title":"Glucocorticoids enhance muscle proteolysis through a myostatin-dependent pathway at the early stage","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"2024112123520564400_bnae016-B179","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1152\/ajpendo.00487.2002","article-title":"Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression","volume":"285","author":"Ma","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.steroids.2015.12.016","article-title":"Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone","volume":"107","author":"Macedo","year":"2016","journal-title":"Steroids"},{"issue":"3","key":"2024112123520564400_bnae016-B181","first-page":"240","article-title":"Serum myokines levels in patients with endogenous cushing syndrome and acromegaly: cross-sectional case\u2212control study","volume":"71","author":"Tsoriev","year":"2016","journal-title":"Ann Russ Acad Med Sci"},{"issue":"1","key":"2024112123520564400_bnae016-B182","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2265.2009.03683.x","article-title":"Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1\u2014implications for steroid-induced myopathy","volume":"73","author":"Inder","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2024112123520564400_bnae016-B183","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1073\/pnas.0303792101","article-title":"Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1","volume":"101","author":"Musar\u00f2","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2024112123520564400_bnae016-B184","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M407517200","article-title":"Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin (PI3K\/Akt\/mTOR) pathway","volume":"280","author":"Latres","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"2024112123520564400_bnae016-B185","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.biocel.2005.04.008","article-title":"Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3\u2005K\/Akt\/GSK-3\u03b2 and PI3K\/Akt\/mTOR-dependent mechanisms","volume":"37","author":"Li","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2024112123520564400_bnae016-B186","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1172\/JCI112500","article-title":"Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats","volume":"77","author":"Zapf","year":"1986","journal-title":"J Clin Invest"},{"issue":"2","key":"2024112123520564400_bnae016-B187","first-page":"H393","article-title":"Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice","volume":"275","author":"Tanaka","year":"1998","journal-title":"Am J Physiol"},{"issue":"3","key":"2024112123520564400_bnae016-B188","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1677\/joe.0.1360525","article-title":"The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers","volume":"136","author":"Miell","year":"1993","journal-title":"J Endocrinol"},{"issue":"11","key":"2024112123520564400_bnae016-B189","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1210\/jc.2017-00696","article-title":"Effects of prednisolone on serum and tissue fluid IGF-I receptor activation and post-receptor signaling in humans","volume":"102","author":"Ramshanker","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B190","first-page":"1595","article-title":"Comparison of multi-frequency bioelectrical impedance and dual-energy X-ray absorptiometry to assess body composition in college-aged adults","volume":"13","author":"Tauber","year":"2020","journal-title":"Int J Exerc Sci"},{"issue":"Suppl 1","key":"2024112123520564400_bnae016-B191","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/ejcn.2012.163","article-title":"Tracking fat-free mass changes in elderly men and women using single-frequency bioimpedance and dual-energy X-ray absorptiometry: a four-compartment model comparison","volume":"67","author":"Moon","year":"2013","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"2024112123520564400_bnae016-B192","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40279-015-0305-z","article-title":"Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment","volume":"45","author":"Fragala","year":"2015","journal-title":"Sports Med"},{"issue":"4","key":"2024112123520564400_bnae016-B193","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jamda.2020.06.052","article-title":"Muscle density, but not size, correlates well with muscle strength and physical performance","volume":"22","author":"Wang","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"2024112123520564400_bnae016-B194","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.surg.2011.09.020","article-title":"A quantitative tool to assess degree of sarcopenia objectively in patients with hypercortisolism","volume":"150","author":"Miller","year":"2011","journal-title":"Surgery"},{"issue":"4","key":"2024112123520564400_bnae016-B195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2265.1983.tb00030.x","article-title":"Effect of treatment of cushing's syndrome on skeletal muscle structure and function","volume":"19","author":"Khaleeli","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2024112123520564400_bnae016-B196","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40618-018-0979-9","article-title":"Ultrasound-based detection of glucocorticoid-induced impairments of muscle mass and structure in Cushing's disease","volume":"42","author":"Minetto","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2024112123520564400_bnae016-B197","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1530\/EJE-10-1169","article-title":"Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing's disease","volume":"164","author":"Minetto","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2024112123520564400_bnae016-B198","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000093866","article-title":"Needle electromyographic findings in 98 patients with myositis","volume":"55","author":"Blijham","year":"2006","journal-title":"Eur Neurol"},{"issue":"1","key":"2024112123520564400_bnae016-B199","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/jnrp.jnrp_323_17","article-title":"Impact of aging on nerve conduction velocities and late responses in healthy individuals","volume":"9","author":"Palve","year":"2018","journal-title":"J Neurosci Rural Pract"},{"key":"2024112123520564400_bnae016-B200","doi-asserted-by":"crossref","first-page":"23002","DOI":"10.1038\/srep23002","article-title":"Effects of systemically administered hydrocortisone on the human immunome","volume":"6","author":"Olnes","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2024112123520564400_bnae016-B201","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased infection risk in Addison's disease and congenital adrenal hyperplasia","volume":"105","author":"Tresoldi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024112123520564400_bnae016-B202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2024112123520564400_bnae016-B203","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/jir.2014.0171","article-title":"Peripheral blood cells from patients with autoimmune Addison's disease poorly respond to interferons in vitro, despite elevated serum levels of interferon-inducible chemokines","volume":"35","author":"Edvardsen","year":"2015","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"2024112123520564400_bnae016-B204","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/en.2013-2085","article-title":"To B or not to B? Glucocorticoid impact on B lymphocyte fate and function","volume":"155","author":"Kovacs","year":"2014","journal-title":"Endocrinology"},{"issue":"9","key":"2024112123520564400_bnae016-B205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing's syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"2024112123520564400_bnae016-B206","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024112123520564400_bnae016-B207","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","article-title":"Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions","volume":"18","author":"Li","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2024112123520564400_bnae016-B208","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1172\/JCI116424","article-title":"Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo","volume":"91","author":"Giorgino","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"2024112123520564400_bnae016-B209","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1172\/JCI116803","article-title":"Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats","volume":"92","author":"Saad","year":"1993","journal-title":"J Clin Invest"},{"issue":"10","key":"2024112123520564400_bnae016-B210","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00125-005-1886-0","article-title":"Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor","volume":"48","author":"Ruzzin","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"2024112123520564400_bnae016-B211","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(98)90184-6","article-title":"Dexamethasone inhibits insulin-stimulated recruitment of GLUt4 to the cell surface in rat skeletal muscle","volume":"47","author":"Weinstein","year":"1998","journal-title":"Metab Clin Exp"},{"issue":"5","key":"2024112123520564400_bnae016-B212","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","article-title":"Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle","volume":"32","author":"L\u00f6fberg","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"2024112123520564400_bnae016-B213","doi-asserted-by":"crossref","first-page":"E1260","DOI":"10.1152\/ajpendo.00345.2009","article-title":"Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people","volume":"297","author":"Short","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"2024112123520564400_bnae016-B214","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/me.2008-0464","article-title":"Direct effect of glucocorticoids on lipolysis in adipocytes","volume":"23","author":"Xu","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2024112123520564400_bnae016-B215","doi-asserted-by":"crossref","first-page":"E681","DOI":"10.1152\/ajpendo.90931.2008","article-title":"High doses of dexamethasone induce increased \u03b2-cell proliferation in pancreatic rat islets","volume":"296","author":"Rafacho","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"2024112123520564400_bnae016-B216","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.2337\/db15-0151","article-title":"Effects of glucocorticoid treatment on \u03b2- and \u03b1-cell mass in Japanese adults with and without diabetes","volume":"64","author":"Sato","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"2024112123520564400_bnae016-B217","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/EJE-09-1034","article-title":"Acute and 2-week exposure to prednisolone impair different aspects of \u03b2-cell function in healthy men","volume":"162","author":"van Raalte","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2024112123520564400_bnae016-B218","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI107473","article-title":"Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man","volume":"52","author":"Wise","year":"1973","journal-title":"J Clin Invest"},{"issue":"8","key":"2024112123520564400_bnae016-B219","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s001250051251","article-title":"Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity","volume":"42","author":"Larsson","year":"1999","journal-title":"Diabetologia"},{"issue":"12","key":"2024112123520564400_bnae016-B220","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1210\/jc.2008-1297","article-title":"Changes in adenosine 5\u2032-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome","volume":"93","author":"Kola","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B221","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"2024112123520564400_bnae016-B222","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/me.2010-0192","article-title":"AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK","volume":"24","author":"Nader","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2024112123520564400_bnae016-B223","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-8587(20)30021-8","article-title":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial","volume":"8","author":"Pernicova","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2024112123520564400_bnae016-B224","doi-asserted-by":"crossref","first-page":"C198","DOI":"10.1152\/ajpcell.00045.2010","article-title":"Adipogenic and lipolytic effects of chronic glucocorticoid exposure","volume":"300","author":"Campbell","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"38","key":"2024112123520564400_bnae016-B225","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","article-title":"Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism","volume":"284","author":"Koliwad","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"2024112123520564400_bnae016-B226","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.1152\/ajpendo.00544.2001","article-title":"Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans","volume":"283","author":"Djurhuus","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B227","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1210\/jc.2012-3523","article-title":"Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo","volume":"98","author":"Hazlehurst","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B228","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1146\/annurev.ph.54.030192.004321","article-title":"Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis","volume":"54","author":"Pilkis","year":"1992","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"2024112123520564400_bnae016-B229","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"2024112123520564400_bnae016-B230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes Rev"},{"issue":"6","key":"2024112123520564400_bnae016-B231","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024112123520564400_bnae016-B232","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/dom.12899","article-title":"Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct","volume":"19","author":"Stimson","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2024112123520564400_bnae016-B233","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024112123520564400_bnae016-B234","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1210\/jc.2019-00420","article-title":"Glucocorticoid replacement affects serum adiponectin levels and HDL-C in patients with secondary adrenal insufficiency","volume":"104","author":"Hayashi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024112123520564400_bnae016-B235","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/eci.12770","article-title":"Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL","volume":"47","author":"Werumeus Buning","year":"2017","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2024112123520564400_bnae016-B236","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-12-0180","article-title":"Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics","volume":"167","author":"Wang","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2024112123520564400_bnae016-B237","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B238","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2265.2006.02638.x","article-title":"Short-term dexamethasone administration does not alter serum adiponectin or resistin concentrations in overweight and obese subjects despite an increase in insulin resistance","volume":"65","author":"Lewandowski","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024112123520564400_bnae016-B239","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/eje.0.1500339","article-title":"Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome","volume":"150","author":"Fallo","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2024112123520564400_bnae016-B240","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archpsyc.55.11.995","article-title":"Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans","volume":"55","author":"Newcomer","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"2024112123520564400_bnae016-B241","first-page":"2075","article-title":"Leptin secretion in Cushing's syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone","volume":"84","author":"Weise","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024112123520564400_bnae016-B242","first-page":"2747","article-title":"Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism","volume":"82","author":"Cizza","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024112123520564400_bnae016-B243","first-page":"600","article-title":"Determinants of serum leptin levels in Cushing's syndrome","volume":"83","author":"Widjaja","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024112123520564400_bnae016-B244","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1210\/jcem.85.10.6891","article-title":"Tissue specificity of glucocorticoid sensitivity in healthy adults","volume":"85","author":"Ebrecht","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B245","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-022-01714-5","article-title":"Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma","volume":"28","author":"Kachroo","year":"2022","journal-title":"Nat Med"},{"issue":"3","key":"2024112123520564400_bnae016-B246","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"3","key":"2024112123520564400_bnae016-B247","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1210\/clinem\/dgaa862","article-title":"Improved urinary cortisol metabolome in addison disease: a prospective trial of dual-release hydrocortisone","volume":"106","author":"Espiard","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B248","doi-asserted-by":"crossref","first-page":"e62236","DOI":"10.7554\/eLife.62236","article-title":"Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial","volume":"10","author":"Chantzichristos","year":"2021","journal-title":"eLife"},{"key":"2024112123520564400_bnae016-B249","doi-asserted-by":"crossref","first-page":"620012","DOI":"10.3389\/fendo.2021.620012","article-title":"Circulating microRNA expression in Cushing's syndrome","volume":"12","author":"Vetrivel","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"2024112123520564400_bnae016-B250","doi-asserted-by":"crossref","first-page":"bnaa007","DOI":"10.1210\/endrev\/bnaa007","article-title":"GDF15: a hormone conveying somatic distress to the brain","volume":"41","author":"Lockhart","year":"2020","journal-title":"Endocr Rev"},{"issue":"5","key":"2024112123520564400_bnae016-B251","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/clinem\/dgz277","article-title":"GDF15 is elevated in conditions of glucocorticoid deficiency and is modulated by glucocorticoid replacement","volume":"105","author":"Melvin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112123520564400_bnae016-B252","first-page":"296069","article-title":"Thrombospondin-1: multiple paths to inflammation","volume":"2011:","author":"Gutierrez","year":"2011","journal-title":"Mediators Inflamm"},{"issue":"23","key":"2024112123520564400_bnae016-B253","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1016\/S0021-9258(17)34336-3","article-title":"Isolation and characterization of a high molecular weight glycoprotein from human blood platelets","volume":"253","author":"Lawler","year":"1978","journal-title":"J Biol Chem"},{"issue":"2","key":"2024112123520564400_bnae016-B254","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-15-0964","article-title":"Thrombospondin-1 is a glucocorticoid responsive protein in humans","volume":"174","author":"Barclay","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2-3","key":"2024112123520564400_bnae016-B255","doi-asserted-by":"crossref","first-page":"e2000078","DOI":"10.1002\/prca.202000078","article-title":"Ex vivo glucocorticoid-induced secreted proteome approach for discovery of glucocorticoid-responsive proteins in human serum","volume":"15","author":"Inder","year":"2021","journal-title":"Proteomics Clin Appl"},{"issue":"6","key":"2024112123520564400_bnae016-B256","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/cen.14108","article-title":"The effect of glucocorticoids on thrombospondin-1, osteocalcin and the thrombospondin-1:osteocalcin ratio in humans","volume":"91","author":"Cesana-Nigro","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024112123520564400_bnae016-B257","first-page":"100256","article-title":"Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome","volume":"24","author":"Bancos","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"2024112123520564400_bnae016-B258","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/npp.2015.235","article-title":"Gene\u2013stress\u2013epigenetic regulation of FKBP5: clinical and translational implications","volume":"41","author":"Zannas","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"34","key":"2024112123520564400_bnae016-B259","doi-asserted-by":"crossref","first-page":"30152","DOI":"10.1074\/jbc.M111.256610","article-title":"The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress","volume":"286","author":"Gallo","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"2024112123520564400_bnae016-B260","doi-asserted-by":"crossref","first-page":"bvaa202","DOI":"10.1210\/jendso\/bvaa202","article-title":"Potential transcriptional biomarkers to guide glucocorticoid replacement in autoimmune Addison's disease","volume":"5","author":"S\u00e6vik","year":"2021","journal-title":"J Endocr Soc"},{"issue":"11","key":"2024112123520564400_bnae016-B261","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1210\/jc.2016-1624","article-title":"FKBP5 mRNA expression is a biomarker for GR antagonism","volume":"101","author":"Bali","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024112123520564400_bnae016-B262","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2217\/epi-2017-0057","article-title":"FKBP5 methylation as a possible marker for cortisol state and transient cortisol exposure in healthy human subjects","volume":"9","author":"Winkler","year":"2017","journal-title":"Epigenomics"},{"issue":"1","key":"2024112123520564400_bnae016-B263","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15252\/emmm.201404601","article-title":"REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids","volume":"7","author":"Baida","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"11","key":"2024112123520564400_bnae016-B264","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00234.2014","article-title":"REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy","volume":"307","author":"Britto","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2024112123520564400_bnae016-B265","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2011.08.017","article-title":"REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade","volume":"412","author":"Kumari","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"2 Pt 1","key":"2024112123520564400_bnae016-B266","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1164\/ajrccm.151.2.7842187","article-title":"Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels","volume":"151","author":"Meeran","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2024112123520564400_bnae016-B267","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/BF03347517","article-title":"Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome","volume":"27","author":"Majnik","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2024112123520564400_bnae016-B268","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jcem-67-5-1025","article-title":"The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects","volume":"67","author":"Nielsen","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2024112123520564400_bnae016-B269","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2010.08.007","article-title":"Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome","volume":"76","author":"Sereg","year":"2011","journal-title":"Steroids"},{"issue":"4","key":"2024112123520564400_bnae016-B270","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00198-009-0978-y","article-title":"Bone turnover in patients with endogenous Cushing's syndrome before and after successful treatment","volume":"21","author":"Szappanos","year":"2010","journal-title":"Osteoporos Int"},{"issue":"3","key":"2024112123520564400_bnae016-B271","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"8","key":"2024112123520564400_bnae016-B272","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/cdd.2015.1","article-title":"The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration","volume":"22","author":"Varadarajan","year":"2015","journal-title":"Cell Death Differ"},{"issue":"8","key":"2024112123520564400_bnae016-B273","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids\u2014the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"2024112123520564400_bnae016-B274","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-020-01185-z","article-title":"MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma","volume":"20","author":"Dai","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2024112123520564400_bnae016-B275","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4070\/kcj.2012.42.2.100","article-title":"Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus","volume":"42","author":"Choi","year":"2012","journal-title":"Korean Circ J"},{"issue":"3","key":"2024112123520564400_bnae016-B276","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1258\/0004563001899212","article-title":"Radioimmunoassay for the measurement of thrombospondin in plasma and breast cyst fluid: validation and clinical application","volume":"37","author":"Hayden","year":"2000","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"2024112123520564400_bnae016-B277","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1677\/jme.0.0330175","article-title":"Gene expression profiling of glucocorticoid-inhibited osteoblasts","volume":"33","author":"Leclerc","year":"2004","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"2024112123520564400_bnae016-B278","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2008-1879","article-title":"Cortisol inactivation by 11\u03b2-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation","volume":"94","author":"Rae","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024112123520564400_bnae016-B279","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1074\/jbc.M407498200","article-title":"FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells","volume":"280","author":"Wochnik","year":"2005","journal-title":"J Biol Chem"},{"issue":"7","key":"2024112123520564400_bnae016-B280","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev"},{"key":"2024112123520564400_bnae016-B281"},{"issue":"1","key":"2024112123520564400_bnae016-B282","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nn.3275","article-title":"Allele-specific FKBP5 DNA demethylation mediates gene\u2013childhood trauma interactions","volume":"16","author":"Klengel","year":"2013","journal-title":"Nat Neurosci"},{"issue":"6","key":"2024112123520564400_bnae016-B283","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1167\/iovs.14-16008","article-title":"DNA methylation analysis of human trabecular meshwork cells during dexamethasone stimulation","volume":"56","author":"Matsuda","year":"2015","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"1","key":"2024112123520564400_bnae016-B284","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-011-2307-3","article-title":"A measure of glucocorticoid load provided by DNA methylation of fkbp5 in mice","volume":"218","author":"Lee","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"2024112123520564400_bnae016-B285","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12020-016-1083-6","article-title":"Reduced DNA methylation of FKBP5 in Cushing's syndrome","volume":"54","author":"Resmini","year":"2016","journal-title":"Endocrine"},{"key":"2024112123520564400_bnae016-B286","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fncel.2014.00313","article-title":"RTP801\/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders","volume":"8","author":"Canal","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"2024112123520564400_bnae016-B287","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-015-3455-9","article-title":"Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials","volume":"27","author":"Amiche","year":"2016","journal-title":"Osteoporos Int"},{"issue":"13","key":"2024112123520564400_bnae016-B288","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00018-012-1211-2","article-title":"The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity","volume":"70","author":"Sadie-Van Gijsen","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"2024112123520564400_bnae016-B289","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024112123520564400_bnae016-B290","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"issue":"1","key":"2024112123520564400_bnae016-B291","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-Q","article-title":"Bone loss in response to long-term glucocorticoid therapy","volume":"8","author":"LoCascio","year":"1990","journal-title":"Bone Miner"},{"key":"2024112123520564400_bnae016-B292","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12891-016-1135-3","article-title":"Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study","volume":"17","author":"Fleishaker","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2024112123520564400_bnae016-B293","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/bonekey.2016.42","article-title":"Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing's syndrome","volume":"5","author":"Belaya","year":"2016","journal-title":"Bonekey Rep"},{"issue":"2","key":"2024112123520564400_bnae016-B294","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650040202","article-title":"Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis","volume":"4","author":"Dempster","year":"1989","journal-title":"J Bone Miner Res"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnae016\/58269417\/bnae016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnae016\/60764147\/bnae016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnae016\/60764147\/bnae016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T23:54:23Z","timestamp":1732233263000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/45\/6\/795\/7682328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":294,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,5,25]]},"published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnae016","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,5,25]]}}}